The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of olaparib combined with breast radiotherapy in patients with triple-negative breast cancer: Final results of the RADIOPARP phase 1 trial.
 
Pierre Loap
No Relationships to Disclose
 
Delphine Loirat
No Relationships to Disclose
 
Frederique Berger
No Relationships to Disclose
 
Manuel Rodrigues
No Relationships to Disclose
 
Louis Bazire
No Relationships to Disclose
 
Jean-Yves Pierga
Honoraria - Novartis (Inst); Sanofi (Inst)
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai Europe (Inst); Exact Sciences; Lilly; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Roche/Genentech; Roche/Genentech (Inst); Seagen
Research Funding - Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca
 
Anne Vincent-Salomon
No Relationships to Disclose
 
Fatima Laki
No Relationships to Disclose
 
Latifa Boudali
No Relationships to Disclose
 
Laurence Raizonville
No Relationships to Disclose
 
Veronique Mosseri
No Relationships to Disclose
 
Anne Jochem
No Relationships to Disclose
 
Mamadou Diallo
No Relationships to Disclose
 
Marc-Henri Stern
No Relationships to Disclose
 
Alain Fourquet
No Relationships to Disclose
 
Youlia M. Kirova
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Accuray; Roche